Nevro Corp.Underwriting Agreement • June 13th, 2016 • Nevro Corp • Surgical & medical instruments & apparatus • New York
Contract Type FiledJune 13th, 2016 Company Industry JurisdictionNevro Corp., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), $150,000,000 principal amount of its 1.75% Convertible Senior Notes due 2021 (the “Underwritten Securities”) and, at the option of the Underwriters solely to cover over-allotments, up to an additional $22,500,000 principal amount of its 1.75% Convertible Senior Notes due 2021 (the “Option Securities”) if and to the extent that the Underwriters shall have determined to exercise the option to purchase such Option Securities granted to the Underwriters in Section 2 hereof. The Underwritten Securities and the Option Securities are herein referred to as the “Securities”. The Securities will be convertible into cash, shares of common stock of the Company, par value $0.001 per share (the “Common Stock”), or a combination of cash and shares of Common Stock at the Company’
INSULET CORPORATION Underwriting AgreementUnderwriting Agreement • June 6th, 2014 • Insulet Corp • Surgical & medical instruments & apparatus • New York
Contract Type FiledJune 6th, 2014 Company Industry JurisdictionInsulet Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), $175,000,000 principal amount of its 2.00% Convertible Senior Notes due 2019 (the “Underwritten Securities”) and, at the option of the Underwriters, up to an additional $26,250,000 principal amount of its 2.00% Convertible Senior Notes due 2019 (the “Option Securities”) if and to the extent that the Underwriters shall have determined to exercise the option to purchase such 2.00% Convertible Senior Notes due 2019 granted to the Underwriters in Section 2 hereof. The Underwritten Securities and the Option Securities are herein referred to as the “Securities”. The Securities will be convertible into cash, shares (the “Underlying Securities”) of common stock of the Company, par value $0.001 per share (the “Common Stock”) or a combination thereof at the Company’s election
GOODRICH PETROLEUM CORPORATION 5.00% Convertible Senior Notes due 2029 Underwriting AgreementUnderwriting Agreement • September 28th, 2009 • Goodrich Petroleum Corp • Crude petroleum & natural gas • New York
Contract Type FiledSeptember 28th, 2009 Company Industry JurisdictionPress release announcing the pricing terms of the Securities, as filed with the Securities and Exchange Commission on September 23, 2009